29
2
3
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T8682 | Vazegepant hydrochloride | Vazegepant HCl | CGRP Receptor |
Vazegepant hydrochloride (Vazegepant HCl) is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study. | |||
T17194 | Ubrogepant | MK-1602 | CGRP Receptor |
Ubrogepant (MK-1602) is an antagonist of calcitonin gene-related peptide receptor that can be used in the acute treatment of migraine studies. | |||
T12293L | Olcegepant | BIBN-4096,BIBN 4096BS | CGRP Receptor |
Olcegepant (BIBN-4096) is an effective and selective non-peptide calcitonin gene-related peptide 1 (CGRP1) receptor antagonist (IC50 of 0.03 nM and Ki of 14.4 pM for human CGRP). | |||
TP1040 | Calcitonin (salmon) | Calcitonin salmon,Salmon calcitonin | CGRP Receptor |
Calcitonin (salmon), a calcium regulating hormone, is used to treat osteoporosis in women who are at least 5 years past menopause. | |||
T4610 | Rimegepant | BMS 927711,BMS-927711,BMS927711,BHV-3000 | CGRP Receptor |
Rimegepant (BMS 927711) is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM. | |||
T6590 | MK-3207 Hydrochloride | MK-3207 HCl | CGRP Receptor |
MK-3207 Hydrochloride (MK-3207 HCl) is a potent CGRP receptor antagonist with IC50 and Kiof 0.12 nM and 0.022 nM, highly selective versus human AM1, AM2, CTR, and AMY3. Phase 2. | |||
T13453 | CGRP antagonist 1 | CGRP Receptor | |
CGRP antagonist 1 is a potent CGRP receptor antagonist with Ki values of 35 nM and IC50 values of 57 nM, respectively.CGRP antagonist 1 can be used for the study of cardiovascular and neurovascular diseases. | |||
TP1323 | CGRP 8-37 (rat) | CGRP Receptor | |
CGRP 8-37 (rat) is a CGRP receptor antagonist, a CGRP fragment with potential anti-injury effects that induces arterial relaxation. | |||
TP1200 | CGRP (83-119), rat TFA | Calcitonin Gene Related Peptide(83-119), rat TFA | Others |
CGRP (83-119), rat TFA (Calcitonin Gene Related Peptide(83-119), rat TFA) is a 37 amino acid calcitonin family of neuropeptide, acts through calcitonin receptor-like receptor. | |||
TP1134L | HCGRP-(8-37) acetate | HCGRP-(8-37) acetate (119911-68-1 free base) | CGRP Receptor |
HCGRP-(8-37) acetate is a human calcitonin gene-related peptide (hCGRP) fragment acetate and also an antagonist of CGRP receptor. | |||
TP1257L | Adrenomedullin (AM) (22-52), human acetate | Adrenomedullin (AM) (22-52), human acetate(159899-65-7 Free base) | CGRP Receptor |
Adrenomedullin (AM) (22-52), human acetate is an antagonist of calcitonin generelated peptide receptor in the hindlimb vascular bed of the cat and an adrenomedullin receptor. | |||
T70820 | MK-8825 | ||
MK-8825 is a CGRP receptor antagonist. | |||
TP1134 | HCGRP-(8-37) | Human α-CGRP (8-37) | |
Rat CGRP-(8-37) (VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF) is a highly selective CGRP receptor antagonist | |||
T16093 | Telcagepant | MK-0974 | Others |
Telcagepant is an orally active antagonist of calcitonin gene-related peptide (CGRP) receptor (Kis: 0.77 nM and 1.2 nM for human and rhesus CGRP receptors, respectively). | |||
T38734 | Vazegepant | Zavegepant,BHV-3500 | |
Vazegepant is an intranasal CGRP receptor antagonist utilized for conducting acute migraine research. | |||
T30537 | BMS-694153 | BMS694153,BMS 694153 | |
BMS-694153 is a potent and selective CGRP receptor antagonist. | |||
TP2044 | α-CGRP(human) | α-CGRP (human) | |
Endogenous calcitonin gene-related peptide receptor (CGRP) agonist. | |||
T75978 | β-CGRP, human TFA | ||
Human β-CGRP TFA (β-CGRP, human TFA) is a calcitonin peptide that functions through interaction with the calcitonin-receptor-like receptor (CRLR) and receptor-activity-modifying protein (RAMP) complex, demonstrating IC50... | |||
T76363 | [Tyr22] Calcitonin Gene Related Peptide, (22-37), rat | ||
[Tyr22] Calcitonin Gene Related Peptide (22-37), rat, refers to a fragment (amino acids 22-37) of the rat calcitonin gene-related peptide (CGRP) that targets the CGRP receptor and adenylate cyclase. While calcitonin is p... | |||
T39522 | HTL22562 | ||
HTL22562 is a calcitonin gene-related peptide (CGRP) receptor antagonist for acute treatment of migraine. | |||
TP1203 | CGRP(83-119), rat | Calcitonin Gene Related Peptide (CGRP) (83-119), rat | |
Calcitonin Gene Related Peptide (CGRP) (83-119), rat is a 37 amino acid calcitonin family of neuropeptide, acts through calcitonin receptor-like receptor. | |||
T26796 | BI-44370 | ||
BI-44370, a CGRP (calcitonin gene-related peptide) receptor antagonist, can be used to treat migraines and other chronic pain. | |||
T12293 | Olcegepant hydrochloride | BIBN-4096 hydrochloride,BIBN4096BS hydrochloride | Others |
Olcegepant hydrochloride is a potent and selective non-peptidethe calcitonin gene-related peptide 1 (CGRP1) receptor antagonist (with IC50 of 0.03 nM for human CGRP). | |||
T73703 | (3R,5R,6S)-Atogepant | ||
Atogepant ((3R,5R,6S)-MK-8031) is the enantiomer of itself and serves as a calcitonin gene-related peptide (CGRP) receptor antagonist, primarily utilized in migraine research. | |||
TP1131 | β-CGRP, human TFA (101462-82-2 free base) | CGRP-II (Human) (TFA),Human β-CGRP (TFA),β-CGRP, human TFA | |
β-CGRP,human tissue is one of the calcitonin peptide, through complex behavior of calcitonin receptor like receptor (CRLR) - and receptor activity - modifying proteins (increased), and 1 and 300 - nM CRLR IC50s/RAMP1 and... | |||
T21558 | MK-3207 | ||
MK-3207 is a potent and orally bioavailable CGRP receptor antagonist (IC 50 = 0.12 nM; K i = 0.024 nM); highly selective versus human AM1, AM2, CTR, and AMY3. IC50 Value: 0.024 nM (Ki, Human CGRP) [1] As other CGRP recep... | |||
T76678 | Eptinezumab | ||
Eptinezumab, a human monoclonal antibody, specifically binds to and blocks the calcitonin gene-related peptide (CGRP) from binding to its receptor, thus acting as a preventive treatment for migraine in adults [1]. | |||
T75934 | AC 187 TFA | ||
AC 187 TFA, a potent and orally active amylin receptor antagonist, exhibits an IC50 of 0.48 nM and a Ki of 0.275 nM. It demonstrates greater selectivity for the amylin receptor over calcitonin and CGRP receptors and has ... | |||
TP2049 | CRSP-1 | ||
Endogenous central calcitonin (CT) receptor agonist that stimulates cAMP formation at a potency 350-fold greater than CT (ED50 values are 0.2 and 71 nM respectively). Displays no activity at calcitonin-gene related pepti... |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T21581L | AC 187 Acetate | AC 187 Acetate (151804-77-2 Free base) | Amylin Receptor |
AC 187 Acetate is a potent antagonist of amylin receptor .AC 187 shows more selective for amylin receptor than calcitonin and CGRP receptors. | |||
TP2167 | β-CGRP, human acetate | β-CGRP, human acetate (101462-82-2 free),CGRP-II (Human) (acetate),Human β-CGRP acetate | CGRP Receptor |
β-CGRP, human acetate is one of calcitonin peptides and acts via the complex of receptor-activity-modifying protein (RAMP) and calcitonin-receptor-like receptor (CRLR) (IC50s: 1 nM and 300 nM for CRLR/RAMP1 and CRLR/RAMP... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-03280 | RAMP3 Protein, Human, Recombinant (hFc) | Human | HEK293 |
RAMP3 belongs to the RAMP family. Members of this family are single-transmembrane-domain proteins, called receptor (calcitonin) activity modifying proteins (RAMPs). RAMPs have a wide biological distribution; high concent... | |||
TMPY-00371 | STC1 Protein, Human, Recombinant (His) | Human | HEK293 |
Stanniocalcin-1 (STC1) is a paracrine factor associated with inflammation and carcinogenesis. STC1 is a secreted glycoprotein hormone and involved in various types of human malignancies. Stanniocalcin-1 (STC1), which has... | |||
TMPY-02839 | Adrenomedullin Protein, Human, Recombinant (hFc) | Human | HEK293 |
Adrenomedullin consists of 52 amino acids and is a member of the adrenomedullin family. It s a a hypotensive peptide and has 1 intramolecular disulfide bond. It seems that adrenomedullin has a slight homology with the ca... |